NCT04110652

Brief Summary

Severe stroke remains an important cause of mortality and morbidity, despite advances in disease management, acute treatment and secondary measures. Among all post-stroke complications, pneumonia constitutes a major complication with a strong impact on morbidity and mortality. Research also showed that a reduction in respiratory muscle and abdominal muscle strength contributed to pulmonary and respiratory dysfunction following a stroke. Low respiratory muscle function decreases the efficacy of rehabilitation because it leads to exercise intolerance in stroke patients. Thus, special exercise programs are needed to improve the pulmonary function and respiratory muscle strength of stroke patients The aim of pulmonary rehabilitation program is to enhance respiratory muscle resistance during breathing, thereby improving respiratory function. Previous studies demonstrated that pulmonary rehabilitation programs improved respiratory functions in cardiac disease and chronic obstructive pulmonary disease patients

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2019

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 3, 2019

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

September 28, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 1, 2019

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 15, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 20, 2020

Completed
Last Updated

December 12, 2019

Status Verified

December 1, 2019

Enrollment Period

10 months

First QC Date

September 28, 2019

Last Update Submit

December 10, 2019

Conditions

Keywords

strokerehabilitationmortality

Outcome Measures

Primary Outcomes (1)

  • Primary outcome: The diagnosis of pneumonia within the first 7 days after admission.

    Diagnosis will be made according to modified criteria of the CDC

    within the first 7 days after admission

Secondary Outcomes (1)

  • Mortality rate

    In-hospital after 30 days

Study Arms (2)

patient

ACTIVE COMPARATOR

40 patients with acute stroke will receive Stroke management based on the guidelines of the American Heart Association/American Stroke Association.(20-22) in addition to pulmonary rehabilitation program.

Other: pulmonary rehabilitation program

control group

PLACEBO COMPARATOR

40 patients with acute stroke will receive Stroke management based on the guidelines of the American Heart Association/American Stroke Association.

Other: pulmonary rehabilitation program

Interventions

The pulmonary rehabilitation program consisting of inspiratory muscle training, manual hyperinflation. chest wall mobilization, rib-cage compression, cough function training, postural drainage and secretion removal will be applied to patient group. The program will be conducted by physical therapists for 30-45 minutes daily during ICU stay. The exercise intensity will be increased gradually over the course. Each patient's performance during the exercise sessions will be recorded and reported regularly.

control grouppatient

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult (≥18 years old).
  • With Acute Ischemic Stroke

You may not qualify if:

  • Hemorrhagic stroke.
  • GCS \< 7 on admission.
  • Clinical signs of infection on admission.
  • Significant pulmonary disease, angina, myocardial infarction or acute heart failure within three months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rehab Abdelaal ELnemr

Alexandria, 123456, Egypt

RECRUITING

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer

Study Record Dates

First Submitted

September 28, 2019

First Posted

October 1, 2019

Study Start

February 3, 2019

Primary Completion

November 15, 2019

Study Completion

January 20, 2020

Last Updated

December 12, 2019

Record last verified: 2019-12

Locations